Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury

Journal of the American Society of Nephrology

Volumn 25, Issue 7, 2014, Pages 1401-1407

  Burger, Dylan ^a   Thibodeau, Jean Francois ^a   Holterman, Chet E ^a   Burns, Kevin D ^a   Touyz, Rhian M ^a,b   Kennedy, Christopher R J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN II; FASUDIL; GLUCOSE; RHO KINASE; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA;

AKITA MOUSE; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC GLOMERULAR INJURY; DIABETIC NEPHROPATHY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GLOMERULOPATHY; HUMAN; HUMAN CELL; MALE; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; PODOCYTE; PODOCYTE MICROPARTICLE; PRIORITY JOURNAL; URINALYSIS; ANIMAL; CELL CULTURE; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; PATHOLOGY; ULTRASTRUCTURE;

ALBUMINURIA; ANIMALS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY GLOMERULUS; MICE; PODOCYTES;

EID: 84907188844     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013070763     Document Type: Article

References (30)

1. Michaud JL, Kennedy CR: The podocyte in health and disease: Insights from the mouse. Clin Sci (Lond) 112: 325-335, 2007
2. Stitt-Cavanagh E, MacLeod L, Kennedy C: The podocyte in diabetic kidney disease. Scientific World Journal 9: 1127-1139, 2009
3. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344, 1999
4. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15: 1379-1383, 2000
5. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997
6. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, De Cosmo S, Viberti G: Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 51: 3083-3089, 2002
7. Quaggin SE, Kreidberg JA: Development of the renal glomerulus: Good neighbors and good fences. Development 135: 609-620, 2008
8. Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM: Microparticles: Biomarkers and beyond. Clin Sci (Lond) 124: 423-441, 2013
9. Boulanger CM, Dignat-George F: Microparticles: An introduction. Arterioscler Thromb Vasc Biol 31: 2-3, 2011
10. Sapet C, Simoncini S, Loriod B, Puthier D, Sampol J, Nguyen C, Dignat-George F, Anfosso F: Thrombin-induced endothelial microparticle generation: Identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 108: 1868-1876, 2006
11. Vion AC, Birukova AA, Boulanger CM, Birukov KG: Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism. Pulm Circ 3: 95-99, 2013
12. PascualM, SteigerG, Sadallah S, Paccaud JP, Carpentier JL, James R, Schifferli JA: Identification of membrane-bound CR1 (CD35) in human urine: Evidence for its release by glomerular podocytes. J Exp Med 179: 889-899, 1994
13. Smalley DM, Sheman NE, Nelson K, Theodorescu D: Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res 7: 2088-2096, 2008
14. Kalani A, Mohan A, Godbole MM, Bhatia E, Gupta A, Sharma RK, Tiwari S: Wilm's tumor- 1 protein levels in urinary exosomes from diabetic patients with or without proteinuria. PLoS One 8: e60177, 2013
15. Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, Hu X, Chawla L, Shen RF, KnepperMA, Star RA: Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int 70: 1847-1857, 2006
16. Rood IM, Deegens JK, Merchant ML, Tamboer WP, Wilkey DW, Wetzels JF, Klein JB: Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 78: 810-816, 2010
17. Chen CL, Lai YF, Tang P, Chien KY, Yu JS, Tsai CH, Chen HW, Wu CC, Chung T, Hsu CW, Chen CD, Chang YS, Chang PL, Chen YT: Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res 11: 5611-5629, 2012
18. Zhang J, Pippin JW, Krofft RD, Naito S, Liu ZH, Shankland SJ: Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. Am J Physiol Renal Physiol 304: F1375-F1389, 2013
19. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J: Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 16: 1733-1741, 2005
20. Ettelaie C, Su S, Li C, Collier ME: Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells. Microvasc Res 76: 152-160, 2008
21. Nomura S, Nakamura T, Cone J, TandonNN, Kambayashi J: Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 40: 173-181, 2000
22. Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM: Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 31: 1898- 1907, 2011
23. Burger D, Kwart DG, Montezano AC, Read NC, Kennedy CR, Thompson CS, Touyz RM: Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: Implications in vascular senescence. J Am Heart Assoc 1: e001842, 2012
24. Nadarajah R, Milagres R, DilauroM, Gutsol A, Xiao F, Zimpelmann J, Kennedy C, Wysocki J, Batlle D, Burns KD: Podocyte-specific overexpression of human angiotensinconverting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int 82: 292-303, 2012
25. Li Y, Ma J, Zhu H, Singh M, Hill D, Greer PA, Arnold JM, Abel ED, Peng T: Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes. Diabetes 60: 2985-2994, 2011
26. Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN: Development of late-stage diabetic nephropathy inOVE26 diabetic mice. Diabetes 53: 3248-3257, 2004
27. SaleemMA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638, 2002
28. Stitt-Cavanagh EM, Faour WH, Takami K, Carter A, Vanderhyden B, Guan Y, Schneider A, Breyer MD, Kennedy CR: A maladaptive role for EP4 receptors in podocytes. J Am Soc Nephrol 21: 1678-1690, 2010
29. Lacroix R, Robert S, Poncelet P, Dignat- George F: Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 36: 807-818, 2010
30. Gardiner C, Ferreira YJ, Dragovic RA, Redman CWG, Sargent IL: Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles 2: 19671, 2013